Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 18149
Country/Region: Vietnam
Year: 2017
Main Partner: Center for Community Health Promotion
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $0 Additional Pipeline Funding: $610,599

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 29,620
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 9,424
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 20,090
HTS_TST Sum of Test Result disaggregates 2018 106
HTS_TST_POS By Test Result: Positive 2018 106
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 86
PP_PREV Age/sex: 20-24 Male 2018 50,000
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 50,000
PP_PREV Sum of Age/Sex disaggregates 2018 50,000
TX_CURR Aggregated Age/Sex: <15 Female 2018 1
TX_CURR Aggregated Age/Sex: 15+ Female 2018 56
TX_CURR Aggregated Age/Sex: 15+ Female 2018 110
TX_CURR Aggregated Age/Sex: 15+ Male 2018 131
TX_CURR Aggregated Age/Sex: 15+ Male 2018 260
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 187
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 371
TX_CURR Sum of Aggregated Age/Sex <15 2018 1
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 187
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 370
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 187
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 371
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 168
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 334
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 87
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 242
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 26
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 72
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 61
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 170
TX_PVLS Numerator: Indication: Routine 2018 87
TX_PVLS Numerator: Indication: Routine 2018 242
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 50
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 99
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 118
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 234
TX_PVLS_den Denominator: Indication: Routine 2018 168
TX_PVLS_den Denominator: Indication: Routine 2018 334
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 187
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 371
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 4
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 7
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 2
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 3
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 5
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 56
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 131
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 110
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 260